With reference to the stock exchange disclosure dated August 26, 2021, on the Appointment of CS of the Company, there was an inadvertent error in the brief profile of Zeal Shah. The revised intimation shall read as follows. In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Procter & Gamble Health has informed that, the Board of directors at their meeting held on August 26, 2021, have appointed Zeal Shah as the Company Secretary (CS) of the Company with effect from August 26, 2021. Brief Profile of Shah is attached.
The above information is a part of company’s filings submitted to BSE.
